306 related articles for article (PubMed ID: 22006749)
1. Application of sentinel node biopsy in breast cancer patients with clinically negative and positive axilla and role of axillary ultrasound examination to select patients for sentinel node biopsy.
Kuru B; Gulcelik MA; Topgul K; Ozaslan C; Dinc S; Dincer H; Bozgul M; Camlibel M; Alagol H
J BUON; 2011; 16(3):454-9. PubMed ID: 22006749
[TBL] [Abstract][Full Text] [Related]
2. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Ultrasound and Pathologic Status of Axillary Lymph Nodes in Clinically Node-negative Breast Cancer Patients.
Bailey A; Layne G; Shahan C; Zhang J; Wen S; Radis S; Richmond B; Partin J; Hazard H
Am Surg; 2015 Sep; 81(9):865-9. PubMed ID: 26350662
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
7. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
8. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
[TBL] [Abstract][Full Text] [Related]
10. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
12. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
Schwartz GF
Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.
Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H
Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665
[TBL] [Abstract][Full Text] [Related]
15. Axillary sentinel node biopsy after neoadjuvant chemotherapy.
Ozmen V; Unal ES; Muslumanoglu ME; Igci A; Canbay E; Ozcinar B; Mudun A; Tunaci M; Tuzlali S; Kecer M
Eur J Surg Oncol; 2010 Jan; 36(1):23-9. PubMed ID: 19931375
[TBL] [Abstract][Full Text] [Related]
16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
17. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
19. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
